HMGB1 and congenital rubella syndrome: A study from 2015 [52], through immunohistochemistry and ELISA analysis, evaluated HMGB1 and RAGE expression in 37 CRS patients and 26 controls, assessing disease severity through SNOT-20 questionnaires, nasal endoscopy, and CT scans.